设为首页
收藏本站
网站地图
|
English
|
公务邮箱
About the library
Background
History
Leadership
Organization
Readers' Guide
Opening Hours
Collections
Help Via Email
Publications
Electronic Information Resources
常用资源
电子图书
期刊论文
学位会议
外文资源
特色专题
内部出版物
在“
Elsevier电子期刊
”中,
命中:
59
条,耗时:小于0.01 秒
1.
A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab
Ozogamicin
in Children and Adolescents with CD33
+
Acute Myeloid Leuk
作者:
Stacey Zahler
1
;
Monica Bhatia
2
;
Angela Ricci
2
;
Sumith Roy
1
;
Erin Morris
1
;
Lauren Harrison
1
;
Carmella van de Ven
1
;
Sandra Fabricatore
1
;
Karen Wolownik
1
;
Erin Cooney-Qualter
3
;
Lee Ann Baxter-Lowe
4
;
Paul Luisi
1
;
Olga Militano
1
;
Morris Kletzel
5
;
Mitchell S. Cairo
1
;
6
;
Mitchell_Cairo@nymc.edu" class="auth_mail" title="E-mail the corresponding author
关键词:
Gemtuzumab
ozogamicin
;
Reduced-intensity conditioning
;
Pediatric AML
;
Allogeneic stem cell transplantation
;
Immunotherapy
刊名:Biology of Blood and Marrow Transplantation
出版年:2016
2.
Antibody-drug conjugates: Current status and future perspectives
作者:
Ré
;
my Gé
;
bleux
a
;
Giulio Casi
b
;
giulio.casi@sennchem.com" class="auth_mail" title="E-mail the corresponding author
关键词:
ADCs
;
antibody-drug-conjugates
;
ALL
;
acute lymphocytic leukemia
;
AML
;
acute myeloid leukemia
;
B-NHL
;
B-cell non-Hodgkin's lymphoma
;
ccRCC
;
clear cell renal cell carcinoma
;
DLBCL
;
diffuse large B-cell lymphoma
;
DAR
;
drug to antibody ratio
;
ECM
;
extra cellular matrix
;
GO
;
Gemtuzumab
ozogamicin
;
IgG
;
Immunoglobulin G
;
mAb
;
monoclonal antibody
;
MDR
;
multidrug resistance
;
MTD
;
maximum tolerated dose
;
NHL
;
non-Hodgkin lymphoma
;
ORR
;
overall response rate
;
PBD
;
pyrrolobenzodiazepines
刊名:Pharmacology and Therapeutics
出版年:2016
3.
Similarity of fractionated versus single dose(s) of gemtuzumab
ozogamicin
as part of the MIDAM salvage regimen in relapsed/refractory acute myeloid leukemia patients
作者:
Pierre Peterlin
a
;
pierre.peterlin@chu-nantes.fr" class="auth_mail" title="E-mail the corresponding author
;
Thierry Guillaume
a
;
Jacques Delaunay
a
;
Mohamad Mohty
a
;
c
;
d
;
Alice Garnier
a
;
Beatrice Mahe
a
;
Viviane Dubruille
a
;
Nicolas Blin
a
;
Maud Voldoire
a
;
Cyrille Touzeau
a
;
Cecile Chauvin
b
;
Thomas Gastinne
a
;
Marie C Bé
;
né
;
e
;
Steven Le Gouill
a
;
Philippe Moreau
a
;
Patrice Chevallier
a
刊名:Seminars in Hematology
出版年:2016
4.
Lineage switch with t(6;11)(q27;q23) from T-cell lymphoblastic lymphoma to acute monoblastic leukemia at relapse
作者:
Yusuke Higuchi
a
;
Kenji Tokunaga
a
;
Yuko Watanabe
a
;
Toshiro Kawakita
b
;
Naoko Harada
b
;
Shunichiro Yamaguchi
a
;
Kisato Nosaka
c
;
Hiroaki Mitsuya
a
;
Norio Asou
a
;
d
;
ktcnasou@saitama-med.ac.jp" class="auth_mail" title="E-mail the corresponding author
关键词:
Lineage switch
;
T-cell lymphoblastic lymphoma
;
acute monoblastic leukemia
;
t(6
;
11)(q27
;
q23)
;
MLL-MLLT4 (AF6)
刊名:Cancer Genetics
出版年:2016
5.
Mcl-1 dependence predicts response to vorinostat and gemtuzumab
ozogamicin
in acute myeloid leukemia
作者:
William E. Pierceall
a
;
wpierceall@eutropics.com" class="auth_mail
;
Ryan J. Lena
a
;
Bruno C. Medeiros
b
;
Noel Blake
a
;
Camille Doykan
a
;
Michael Elashoff
a
;
Michael H. Cardone
a
;
Roland B. Walter
c
;
d
;
e
;
rwalter@fhcrc.org" class="auth_mail
关键词:
AML
;
Biomarker
;
Personalized medicine
;
HDAC inhibitors
;
Gemtuzumab
ozogamicin
刊名:Leukemia Research
出版年:May 2014
6.
Feasibility of Allografting in Patients with Advanced Acute Lymphoblastic Leukemia After Salvage Therapy With Inotuzumab
Ozogamicin
作者:
Partow Kebriaei
1
;
pkebriaei@mdanderson.org
;
Kaci Wilhelm
1
;
Farhad Ravandi
2
;
Mark Brandt
2
;
Marcos de Lima
1
;
Stefan Ciurea
1
;
Laura Worth
3
;
Susan O'Brien
2
;
Deborah Thomas
2
;
Richard E. Champlin
1
;
Hagop Kantarjian
2
关键词:
Acute lymphoblastic leukemia
;
Allogeneic hematopoietic stem cell transplantation
;
Inotuzumab
ozogamicin
;
Venoocclusive disease
刊名:Clinical Lymphoma Myeloma and Leukemia
出版年:2013
7.
High Response Rate for Treatment With Gemtuzumab
Ozogamicin
and Cytarabine in Elderly Patients With Acute Myeloid Leukemia and Favorable and Intermediate-I Cytogenetic Risk
作者:
Sigal Tavor
1
;
tavorsigal@yahoo.com
;
Einam Rahamim
1
;
Nadav Sarid
1
;
Uri Rozovski
1
;
Lili Gibstein
1
;
Freddy Aviv
1
;
Ilya Kirsner
1
;
Elizabeth Naparstek
1
;
2
关键词:
Acute myeloid leukemia (AML)
;
Cytogenetic analysis
;
Elderly
;
Gemtuzumab
ozogamicin
刊名:Clinical Lymphoma Myeloma and Leukemia
出版年:2012
8.
Phase I study of dose dense induction and consolidation with gemtuzumab
ozogamicin
and high dose cytarabine in older adults with AML
作者:
Arati V. Rao
a
;
c
;
arati.rao@dm.duke.edu
;
David A. Rizzieri
a
;
Carlos M. DeCastro
b
;
Louis F. Diehl
b
;
Anand S. Lagoo
d
;
Joseph O. Moore
b
;
Jon P. Gockerman
b
关键词:
Elderly
;
AML
;
HiDAC
;
Gemtuzumab
Ozogamicin
刊名:Journal of Geriatric Oncology
出版年:2012
9.
High dose cytarabine plus gemtuzumab
ozogamicin
for patients with relapsed or refractory acute myeloid leukemia: Cancer and Leukemia Group B study 19902
作者:
Richard M. Stone
a
;
rstone@partners.org
;
Barry Moser
b
;
Ben Sanford
b
;
Philip Schulman
c
;
Jonathan E. Kolitz
d
;
Steven Allen
d
;
Wendy Stock
e
;
Ilene Galinsky
a
;
Ravi Vij
f
;
Guido Marcucci
g
;
David Hurd
h
;
Richard A. Larson
e
;
for the Cancer
;
Leukemia Group B
关键词:
Gemtuzumab
ozogamicin
;
Acute myeloid leukemia
;
Cytarabine
;
Relapse
刊名:Leukemia Research
出版年:2011
10.
Are immunoconjugates approaching 鈥渟tandard of care鈥?in AML?
作者:
Elihu Estey
关键词:
225Actinium
;
acute myeloid leukemia
;
acute promyelocytic leukemia
;
AML
;
antigen
;
antibody
;
APL
;
brentuximab
;
CD33
;
CD30
;
CD45
;
gentuzumab
ozogamicin
;
immunoconjugates
;
SGN-CD331
刊名:Best Practice Research Clinical Haematology
出版年:September, 2013
1
2
3
4
5
6
按检索点细分(59)
题名(33)
关键词(25)
文摘(42)
按出版年细分(59)
2027年及以后(4)
2016年(4)
2013年(1)
2012年(7)
2011年(2)
2010年(6)
2009年(5)
2008年(3)
2007年(7)
2006年(5)
2005年(5)
2004年(2)
2003年(7)
2001年(1)
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via
email
.